Full-year net profit for traditional Chinese medicine firm Eu Yan Sang International rose by 11 per cent to $18.2 million compared with a year ago.
Releasing its earnings after markets closed today, the mainboard-listed company said its revenue for the year ended June 30 grew by 13 per cent to $326.9 million compared with the previous financial year.
It said good sales performance in Hong Kong and Malaysia boosted its earnings.
Eu Yan Sang's group chief executive Richard Eu said: "Operating profit of our core markets, namely Hong Kong, Malaysia and Singapore, grew 18 percent year-on-year."
Eu Yan Sang's fourth-quarter performance, however, could not match its full-year results.
For the fourth quarter, profit dropped by 49 per cent to $4.66 million compared with a year ago. The drop came despite revenue for the quarter rising by 11 per cent to $77.3 million.
The company has proposed a final dividend of 2.2 cents per share.